Healthcare Realty Trust (NYSE:HR) Rating Lowered to Sell at StockNews.com

Healthcare Realty Trust (NYSE:HR) was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating in a report issued on Thursday.

Other equities analysts have also recently issued reports about the company. Wedbush restated an “outperform” rating and set a $16.00 target price on shares of Healthcare Realty Trust in a report on Thursday, February 20th. Wells Fargo & Company reduced their price objective on Healthcare Realty Trust from $17.00 to $16.00 and set an “underweight” rating on the stock in a research note on Monday, March 10th. Scotiabank decreased their price objective on Healthcare Realty Trust from $18.00 to $17.00 and set a “sector perform” rating for the company in a research note on Tuesday, February 25th. Jefferies Financial Group cut Healthcare Realty Trust from a “buy” rating to a “hold” rating and cut their price target for the company from $19.00 to $17.00 in a research note on Thursday, January 2nd. Finally, JPMorgan Chase & Co. cut Healthcare Realty Trust from an “overweight” rating to a “neutral” rating and set a $19.00 price objective for the company. in a research report on Friday, December 20th. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, Healthcare Realty Trust presently has an average rating of “Hold” and an average price target of $17.00.

Healthcare Realty Trust Price Performance

NYSE:HR opened at $16.76 on Thursday. The company’s 50-day moving average is $16.66 and its two-hundred day moving average is $17.23. Healthcare Realty Trust has a 1-year low of $13.64 and a 1-year high of $18.90. The firm has a market capitalization of $5.88 billion, a price-to-earnings ratio of -9.41 and a beta of 0.97.

Healthcare Realty Trust (NYSE:HR) last released its quarterly earnings data on Wednesday, February 19th. The real estate investment trust reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.39 by $0.01. The firm had revenue of $309.77 million for the quarter, compared to analysts’ expectations of $303.81 million. Healthcare Realty Trust had a negative return on equity of 11.20% and a negative net margin of 51.60%. The firm’s quarterly revenue was down 6.3% on a year-over-year basis. During the same period in the prior year, the firm posted $0.39 earnings per share. As a group, equities analysts anticipate that Healthcare Realty Trust will post 1.59 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Healthcare Realty Trust

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Smartleaf Asset Management LLC lifted its position in Healthcare Realty Trust by 59.0% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,650 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 612 shares during the period. Blue Trust Inc. lifted its holdings in shares of Healthcare Realty Trust by 130.3% during the fourth quarter. Blue Trust Inc. now owns 1,635 shares of the real estate investment trust’s stock worth $30,000 after purchasing an additional 925 shares during the period. Synergy Investment Management LLC purchased a new position in Healthcare Realty Trust in the 4th quarter valued at $36,000. Lazard Asset Management LLC acquired a new position in Healthcare Realty Trust in the 4th quarter valued at $45,000. Finally, Jones Financial Companies Lllp boosted its holdings in shares of Healthcare Realty Trust by 68.7% in the fourth quarter. Jones Financial Companies Lllp now owns 3,067 shares of the real estate investment trust’s stock valued at $52,000 after acquiring an additional 1,249 shares in the last quarter.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.